Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001578563-25-000238

Director acquired 6,927,419 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Foundation Fighting Blindness Retinal Degeneration Fund · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-05 Conversion : show line 1 in the form +6,927,419 9,492,171 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-05 Conversion : show line 2 in the form Series A Non-Voting Convertible Preferred Stock −6,927.42 0 D
Loading xslF345X05/primary_doc.xml…